Abstract

Epitope tags are widely employed as tools to detect, purify and manipulate proteins in various experimental systems. We recently introduced the ALFA-tag together with two ALFA-specific single-domain antibodies (sdAbs), NbALFA and NbALFAPE, featuring high or intermediate affinity, respectively. Together, the ALFA system can be employed for a broad range of applications in microscopy, cell biology and biochemistry requiring either extraordinarily stable binding or mild competitive elution at room temperature. In order to further enhance the versatility of the ALFA system, we, here, aimed at developing an sdAb optimized for efficient elution at low temperatures. To achieve this, we followed a stringent selection scheme tailored to the specific application. We found candidates combining a fast capture of ALFA-tagged proteins with an efficient competitive elution at 4 °C in physiological buffer. Importantly, by employing a structure-guided semisynthetic library based on well-characterized NbALFA variants, the high specificity and consistent binding of proteins harboring ALFA-tags at either terminus could be maintained. ALFA SelectorCE, a resin presenting the cold-elutable NbALFACE, is an ideal tool for the one-step purification of sensitive protein complexes or temperature-labile enzymes. We believe that the general approach followed during the selection and screening can be transferred to other challenging sdAb discovery projects.

Highlights

  • Camelid single-domain antibodies [1], referred to as nanobodies®, are employed in fundamental research and clinical diagnostics, and as promising candidates for therapeutic applications

  • We present NbALFACE, a new member of the ALFA system, which proves to be an ideal tool for the purification and elution of ALFA-tagged target proteins at cold temperatures in physiological buffer

  • We ensured an enrichment of single-domain antibodies (sdAbs) that stably associated with ALFA-tagged proteins while still allowing for an efficient release at 4 ◦ C

Read more

Summary

Introduction

Camelid single-domain antibodies (sdAbs) [1], referred to as nanobodies® (a trademark of Ablynx), are employed in fundamental research and clinical diagnostics, and as promising candidates for therapeutic applications. The selection of sdAbs from immune libraries generated from peripheral blood mononuclear cells (PBMCs) of immunized alpacas, llamas or camels is a straightforward process, provoking the required immune responses in these animals can be challenging This is the case, in particular, for toxic or highly conserved proteins. Immunizing animals is a time-consuming process with intrinsically unpredictable outcomes regarding the nature, quality and specificity of the sdAbs obtained. To overcome these limitations, some fully synthetic libraries have been developed, typically based on Biomolecules 2021, 11, 269.

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call